chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Systemic: low platelet-Mild, Additional Details: pt came in 6/27 for their medication due to recent discharge from hospital. pt received shingrx on 6/10 then experienced bumps that resembled shingles 4 days after. she was then admitted to the hospital where she was diagnosed with low platlet count
headache, body sweats, muscle aches at injection site.  Symptoms resolved in 24 hrs.
Warm induration 16 x 10 cm (L) upper arm reaction. Treated with antibiotic/MOTRIN. Had to go to ER 2-27-13.
After the initial vaccination she could not walk; She had extreme inflammation/she blew up from the knee down to her ankles.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient received BNT162b2 (BNT162B2), on 11Jun2021 as dose 1, single (Lot number: EW0196) at the age of 68 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: GAIT INABILITY (non-serious) with onset Jun2021, outcome "recovered" (2021), described as "After the initial vaccination she could not walk"; ARTHRITIS (non-serious) with onset Jun2021, outcome "recovered", described as "She had extreme inflammation/she blew up from the knee down to her ankles.". The events "after the initial vaccination she could not walk" and "she had extreme inflammation/she blew up from the knee down to her ankles." required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient reported that before getting the vaccine she was healthy with no issues and took no medicines at all. The patient received the first injection in right upper arm, exact time unknown; sometime in early afternoon. After the initial vaccination she could not walk. She had extreme inflammation. This occurred within two weeks of getting the first injection. The event extreme inflammation as clarified, she mentioned she blew up from the knee down to her ankles. Confirmed she no longer had it. It went away when she got covid. It eliminated the inflammation. Attempted to clarify if she recovered completely or with lasting effects, and stated she overcame it. The event could not walk confirmed no longer had this issue, it improved a year ago. The patient had testing done to determine why she was having inflammation. However, reporter did not know any dates or additional information to provide. Stated that was in the hospital computer and not something she would have. There were no prior vaccinations (within 4 weeks). She had several doctors. She was seeing one in a state and had one in a state. There were a few, but had no additional details to provide.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201318002 same patient/drug, different dose/event;US-PFIZER INC-202201318929 same patient/drug, different dose/event;
Left arm stiff and achy, within a few hours, post vax, especially left elbow, and after 2nd dose had extreme stiffness and aching in both knees X 4 days. Still have symptoms in knees and elbows.
Pain and immobility in left arm starting approximately 8 hours after shots. Chills, body aches, pain and rash across upper arm. Dr. prescribed antibiotics and steroids. Pain was relieved within a day but rash lasted over a week.
EXPIRED VACCINE GIVEN; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 04-OCT-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 04-OCT-2021, the patient experienced expired vaccine given. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine given was not reported. This report was non-serious.
pt recvd vax;w/in several hrs, devel redness, induration,swelling & warmth at inject site;
APPROXIMATELY 18 HRS AFTER INJECTION DEVELOPED A LARGE BASEBALL SIZE RED/BRUISED APPEARING AREA TO BACK OF LEFT ARM AT SITE OF MMRV INJECTION.  MOTHER INSTRUCTED TO USE MOIST COMPRESSES, TYLENOL/MOTRIN FOR PAIN/DISCOMFORT AND BENADRYL EVERY 6 HOURS X24-48 HOURS.
devel onset of bruising 23JUL95;dx ITP 25JUL95- tx w/IV & Globulin w/excellent results w/in 72 hr
BL leg pain, aching some weakness.  Follow-up received states - I don't know lot numbers, or any other vaccine info. Flu vaccine was given at Health Dept. - First shot was in batch that was frozen- went to have another in case 1st one wasn't any good. Stiff, trouble walking, pain in neck shoulders, arms, and hands, hands and wrist swelling, alot of pain.
In Sept 2010 started with ear infection, or pink eye. eyes were red, nymph node behind the ear was swollen. Urgent care stated no pink eye. Next few days he declined.  His balance was off, couldn't walk correctly.  Following week couldn't walk with out falling, tripping. Went to see PCP in October.  In Nov he was slurring his speech, eyes were bouncing, making a mess when eating. Constantly falling.  Ataxia, IVIG, Steroids over 14months got better, but it hasn't gone away.
I woke up the following morning with extreme vertigo, which is still with me one week later, but is lessening.
12 hours after vaccines had complex febrile seizure that resulted in intubation x 4 days. No cause of fever identified.
father reports 5min p/vax child c/o of eyes swelling, chest felt tight approx 1hr 15min eyes completely swollen, joints hurting, SOB, chest tight;tx @ ER w/ IV w/ 6 unk shots-swelling reduced 2 1/2 hr-discharged w/joint aches 1 1/2 days.
pt recvd vax 31JUL92 & 1AUG92 awoke w/flu-like illness, fever of 101, enlarged cervical nodes on rt shoulder & arm pain, face flushed & ha/; MD dx flu;
Pain in right shoulder.  Limited range of motion.  Unable to reach or hold much much weight with it.  Has gotten worse and worse over time.  At first I thought it was just initial pain from the shot that would go away but it has not gone away and has gotten to the point now where I can hardly move it without any pain and it hurts even without moving it.
Pt developed a hyperpigmented macular rash with irregular borders (and not evenly hyperpigmented) at right upper chest (to above the nipple), involving lateral aspect of upper border of the trapezius, proximal 50% of the right upper arm. Is slightly darker than his normal skin, and barely noticeable on his upper arm. At the right antecubital fossa, he has several linear (horizontally oriented) streaks that are slightly raised and hyperpigmented. No other rash or symptoms. Rash is not pruritc or tender.
High fever (103), chills, headache, body ache, loss of appetite, severe diarrhea until moderate hemorrhoids.
This spontaneous report as received from a pharmacist refers to a 65 years old female patient. Pertinent medical history was not reported. The patient had no history of drug reactions/allergies. The patient was vaccinated with ZOSTAVAX subcutaneously on 24-SEP-2012. Reported lot number was H011049 with expiry date 05-SEP-2013. No other co-suspects were reported. No concomitant medications were reported. On 25-SEP-2012 the patient experienced redness and swelling at the injection site, nausea, vomiting, lightheadedness, and dizziness. No treatment was given for the events. The patient sought medical attention; she called the reporting pharmacist. At the time of report the patient was recovering. The relatedness per reporter for the events was unknown for ZOSTAVAX. Additional information has been requested.
This spontaneous report was received from a doctor of pharmacy refers to a 48-year-old female patient with no pertinent medical history. Patient was allergic to soy. On 06-NOV-2012 the patient was vaccinated with, 0.5 milliliter PNEUMOVAX 23 (lot # and expiration not reported) intramuscularly. No concomitant medications were reported. On 06-NOV-2012 patient experienced swelling, slight redness, pain and warmth to touch at the injection site area and whole upper right arm. Pharmacist also noted that the patient stated that she had shortness of breath on 06-NOV-2012. Treatment was rendered for the events. Patient was given BENADRYL, CLARITIN, ALEVE and cool compress. No lab studies were performed. Patient did not recover from the events at the time of this report. Patient sought medical attention for the events by contacting the pharmacist. No further information is available. Additional information has been requested.
Your child received a vaccination at our clinic during the period between February 28 and April 16, 2020. During the period between February 28th, 2020 and March 2nd, 2020, our data logger had a technical malfunction that we were not aware of and it stopped sending its temperature recordings to the system. During that period the fridge never stopped working. The temperature logs of the fridge before and after the incident were always within required range. Our fridge has been always in a perfect new condition and never had any temperature problems previously. There was no power outage in the area or inside the office during that period as well.    The CDC requires continuous temperature monitoring of all vaccines and due to lack of continuous temperature data documentation, the vaccine manufacturers have determined that the doses administered on these dates should be re-administered to ensure proper effectiveness.
No adverse event, but administered incorrect vaccine. Requested varicella vaccine, received Zostavax.
As stated by patient: chills, vomiting. heaviness in chest, metallic taste in mouth; lasting 4 days. Reported to provider at time Hep B #2 due.
vials were stored in the refrigerator and thawed on same day of administration; Vial was expired on 04-APR-2022 and administered on 13-MAY-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial was expired on 04-APR-2022 and administered on 13-MAY-2022) and PRODUCT STORAGE ERROR (vials were stored in the refrigerator and thawed on same day of administration) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial was expired on 04-APR-2022 and administered on 13-MAY-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vials were stored in the refrigerator and thawed on same day of administration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vial was expired on 04-APR-2022 and administered on 13-MAY-2022) and PRODUCT STORAGE ERROR (vials were stored in the refrigerator and thawed on same day of administration) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported  HCP stated that there was no information about side effects after administration of expired dose. The vial did not undergone any temperature excursion.
24 hours after receiving the 1st dose vaccine I suffered from abdominal pain/cramping and vaginal bleeding. The vaginal bleeding was heavy at times and lasted for 60 hours. The abdominal pain continues as I fill this report out which is currently 72 hours. I was seen today by a gynecologist who performed a pap smear and ordered an ultra sound.
Large area of erythema/induration over medial aspect of left arm extending about 3 inches below elbow.
This spontaneous report as received from a registered nurse refers to unspecified number of patients. On an unknown date, the patients were vaccinated with some improperly stored doses of COMVAX (dose, route and lot # not reported). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.  No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). No concomitant medication information was provided. The vial was initially stored in refrigerator on 7-Jun-2022. The vial did not undergo any temperature excursions. It was reported that a total of 35 doses were given from 4 vials for approximately 40 patients. The dates of administration of the vaccines were reported as 1Apr2022, 5Apr2022, 6Apr2022, 8Apr2022, 11Apr2022, 12Apr2022, 13Apr2022, 14Apr2022, 22Apr2022, 9Jun2022, 10Jun2022, 13Jun2022, 18Jun2022 and 22Jun2022. The dates of vaccine administration were not reported, and it was unknown whether patient took first, second or first and or second booster doses. No treatment medication information was provided.
following day: calf pain so severe he couldnt walk for 3 days, increasing coughing and wheezing, scalp felt like it was on fire, ongoing brain fog.
Patient complaint of pain, redness, and swelling at the injection site and along arm (left). Pt was advised to take ibuprofen.
2-3 days after first dose of Pfizer C19, started having ligament pain and tightness. Has improved somewhat but not resolved 3+ months later.
Patient reports rash on neck and arm at injection site, bump on breast, increased mosquito bites, bilateral feet skin peeling, and ankles swollen.  Patient reports this is her second vaccine. registry only reports one vaccination occurred. Patient is from another area, however.  Patient called pharmacy 8/12/2021 at 115 pm to report adverse events. Patient was boarding a plane. Patient asked about taking benadryl for the rash. I also recommended putting feet up for swelling, monitoring feet/ankle swelling and rash, using a cold pack on swelling, and calling physician if worsening symptoms.
Information has been received from a 51 year old male consumer with a history of drug reaction to CEFZIL, who on 28-MAY-2008 was vaccinated with his first dose of GARDASIL (Lot #, site and route not reported).  The patient received his first dose of the vaccine "as prescribed by his physician because he was told by his girlfriend that she has 1 strain of HPV that can cause cervical cancer".  On 28-MAY-2008, "right after receiving the first dose" he experienced "sore in the injection site".  The patient sought unspecified medical attention.  On an unspecified date, the patient recovered from "sore in the injection site after receiving first dose".  No additional information was provided.  Additional information is not expected.
pt recv vax & devel urticaria 5mm x 7mm 3:45, HR 120, RR32 4:50 clear;4:00 clear; red area HR 120-140 "mad" DPH given;4:15 clear; redness fading (better) 4:30 clear;redness fading;4:45 clear hives gone;
felt really tired; eyes has a burning feeling behind them; joint pain; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) via unspecified route of administration on 13Jan2021 at single dose for Covid-19 immunization. Medical history and concomitant medications were not reported. The patient received her first dose of the COVID-19 vaccine yesterday, 13Jan2021. The patient informed that she felt really tired now, and her eyes has a burning feeling behind them, and she has joint pain (Jan2021). The patient wanted to know how long do the side effects last. The outcome of the events felt really tired, eyes has a burning feeling behind them, joint pain was unknown.  Follow-up activities are possible, information on the batch number has been requested.
Information has been received from a nurse practitioner concerning a 17 year old female with attention deficit/hyperactivity disorder and allergic rhinitis who on 04-FEB-2008 was vaccinated with the first dose of GARDASIL. Concomitant therapy included MENACTRA, tuberculin purified protein derivative and hormonal contraceptives (unspecified). On 06-FEb-2008 the patient experienced pain, swelling, warmth and numbness at the injection site. The patient sought unspecified medical attention. No diagnostic laboratory studies were performed. The patient was treated with BENADRYL. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Fever and headache for several days. Day of vaccine I started with a funny taste in my mouth. I still have it almost 3 weeks later. I continue to taste it with whatever I eat.. This same taste/odor can be smelled when I have a bowel movement. The smell is so awful! That is why I am reporting this.
body aches (mainly upper body) that have not gone away since the booster shot was received.
Patient experienced severe dizziness around 5 minutes after the vaccine. We had him lie down on the floor which made him get better. 911 was called right away. BP was measured, 102/68. Baseline BP is unknown. Pt was brought to the hospital by the medics.
She states that right after the Pfizer Covid-19 1st vaccination she started to have tingling sensation, HA, SOB, throat swelling feeling, fatigue, and arm angioedema within mins after receiving the vaccine. Patient was treated with Benadryl and Tylenol at the vaccination sites and then discharged with stable condition. However, over the next couple wks she started to develop progressing weakness and palpitation. She was so short of breath and fatigue so that she can not walking more than 15-20 steps. Patient was hospitalized in 06/2021 for the evaluation of pulm embolism and suspected myocarditis, but CT PE scan, troponin, and cardiac MRI all came back unremarkable. The only thing found during the hospitalization was elevated IGE and high ANA levels. At current time, the allergist did not find any correlated allergy issues that explain patient symptoms and also the rheumatologist can not find any other findings other than elevated ANA levels. Patient is still wheelchair bound and having palpitation and fatigue. Cardiologist is ordering tilt table testing to try to see if patient fits the diagnosis of POTS even though this diagnosis still could not explain patient other symptoms.
mild discomfort in his arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious), outcome "unknown", described as "mild discomfort in his arm".  No follow-up attempts are possible. No further information is expected.
Low fever on 3/29. Increasingly high to 105.3 on 3/31. Urgent care visit on 3/31 followed by emergency room trip for fluids. Fever still ~104 on 4/2. Additional office visit.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 61-year-old male patient received BNT162b2 (BNT162B2), on 08Aug2022 at 11:00 as dose 3 (booster), single (Lot number: FP7139) at the age of 61 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Tetracyclines, reaction(s): "Dermographism", notes: known allergies: tetracyclines. Vaccination history included: BNT162b2 (prev dose product=COVID 19,, Prev dose brand=Pfizer,, Prev dose brand unknown=False,, Prev dose lot number=ER8733, Prev dose lot unknown=False,, Prev dose administration date=27Mar2021,, Prev dose dose number=1), administration date: 27Mar2021, when the patient was 59-year-old, for COVID-19 Immunization; BNT162b2 (prev dose product=COVID 19,, Prev dose brand=Pfizer,, Prev dose brand unknown=False,, Prev dose lot number=FF2593,, Prev dose lot unknown=False,, Prev dose administration date=21Oct2021,, Prev dose dose number=2, Prev dose vaccine location=Left arm), administration date: 21Oct2021, when the patient was 60-year-old, for COVID-19 Immunization. The following information was reported: VACCINATION SITE RASH (non-serious) with onset 10Aug2022, outcome "not recovered", described as "rash on the injection arm (right arm) on my upper inner arm". Therapeutic measures were taken as a result of vaccination site rash. Additional information: Patient did not receive any other vaccine in four weeks. Patient did not receive other medications in two weeks. Patient did not have COVID prior vaccination. Patient did not test COVID post vaccination. He developed a 5 cm x 10 cm rash on the injection arm (right arm) on his upper inner arm below his arm pit and treated with OTC Topical cortisone ointment.
Red cheeks; Warm cheeks; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red cheeks) and FEELING HOT (Warm cheeks) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL, SIMVASTATIN, CICLOSPORIN (RESTASIS), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), FISH OIL, BIOTIN, COLECALCIFEROL (VITAMIN D 3) and ZINC for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced ERYTHEMA (Red cheeks) and FEELING HOT (Warm cheeks). At the time of the report, ERYTHEMA (Red cheeks) and FEELING HOT (Warm cheeks) outcome was unknown.            No Treatment information  provided